India has a rich heritage in its traditional systems of medicine including Ayurveda, Siddha, and Unani and there has been a lot of research conducted in this area. This paper examines the published contribution of Indian scientists to "Traditional Medicine" research in the last five years (2012)(2013)(2014)(2015)(2016)(2017). Medline was searched for English language publications with Pubmed as the interface, using two sets of search terms: "Traditional Medicine" AND India and "Traditional Medicines" and India. A filter for last 5 years was applied (2012)(2013)(2014)(2015)(2016)(2017). Papers were included if at least one author was from India. The search yielded n = 670 papers of which 483 met the inclusion criteria. Of the 483, 63 papers resulted from international collaborations and there was a wide distribution of publications from all across the country. As many as 393/483 (81%) articles were published on plants and the strategy remained evaluation of one or other extract or compound from a plant for efficacy, safety or development of a method. However, there was no commonality of purpose, no thread in the diseases covered, no direction. A number of clinical studies have been reported in conditions ranging from cancer and arthritis to malaria and dengue. As many as 66/483 (13%) of the papers identified were field surveys recording traditional medicine practices -either documenting all the plants (and sometimes insects) used by tribes or recording the treatments used for certain diseases. It is clear from this data that the large part of work that is undertaken under the heading of TM is related to plant pharmacology with no efforts to develop a drug from them. There is indeed very little work done related to "Traditional Medicine".
Introduction
The World Health Organisation (WHO) defines traditional medicine as "… the sum total of knowledge, skills, and practices based on the theories, beliefs, and experiences indigenous to different cultures, whether explicable or not, used in the maintenance of health, as well as in the prevention, diagnosis, improvement or treatment of physical and mental illness". On the other hand, herbal medicines "include herbs, herbal materials, herbal preparations and finished herbal products, that contain as active ingredients parts of plants, or other plant materials, or combinations". And further, traditional use of herbal medicines "refers to the long historical use of these medicines. Their use is well established and widely acknowledged to be safe and effective, and may be accepted by national authorities" (WHO Report, 2017) . Thus, traditional medicine (TM) includes not only herbal medicines, but also other therapeutic modalities as well as therapeutic procedures.
India has a rich heritage in its traditional systems of medicine including Ayurveda, Siddha, and Unani and there has been a lot of research in this area (Ravishankar and Shukla, 2007; Prasad, 2002) .
In a very promising action, in late 2015, the Govt. of India issued a very important notification from the Ministry of Health and Family Welfare, viz. G.S.R. 918(E) dated 30th November 2015 in which a "Phytopharmaceutical drug" was officially defined and included under the regulatory ambit. (CDSCO, 2015) .
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Methods
Only Medline was searched for English language publications with Pubmed as the interface using two sets of search terms "Traditional Medicine" and India and "Traditional Medicines" and India. A filter for last 5 years was applied (2012) (2013) (2014) (2015) (2016) (2017) . Papers were included if at least one author was from India. The following demographics were recorded: 
Results and Discussion

Demographics
The search yielded n = 670 papers of which 483 met the inclusion criteria (at least one author from India) and the yearly distribution of the papers is depicted in Table 1 . Of the 483, 63 papers resulted from international collaborations. While New Delhi contributed the maximum number of papers, there was a wide distribution of publications across the country [including from places like Belthangdi from Karnataka (n=1) or Silchar in Assam (n=6)]. Table 2 summarises the distribution of papers city-wise of the top 7 cities. It was interesting to note that a metro like Mumbai with a number of internationally acclaimed research centres is last in the list (with only 9 papers), suggesting that very little work is being pursued in TM in this city! Tamil Nadu was most prolific among the states with 76 papers (Table 3 ). The North-Eastern States had as many as 39 papers altogether. This is a very interesting observation as the Government of India has invested highly in these states for research with special programmes (http://www.dbtindia.nic.in/ twinning-rd-projects-cftp-2017-18/, http://www.fistdst.org/html-flies/north-east-package.htm, https:// www.fundsforngos.org/developing-countries-2/india/ call-for-proposal-under-north-east-seed-grantscheme-promoting-research-activities-in-the-northeast-region/, http://www.mdoner.gov.in/) and it is heartening to note this outcome. Of all the 39 papers, as many as 13 were surveys of the region recording the tribal TM practices. In addition, 20 studied efficacy of the local plants used in TM.
We were able to obtain only 214 full texts of the 483 publications, which were available for free. This remains a limitation to an extent. However, all relevant data was available in the abstracts and this was extracted. Approximately 80% of the papers were original papers (380/483; 79%) and the rest were review articles (103/483; 21%).
Plant Pharmacology
The search terms used for this review included "Traditional Medicine/s" and of the 483 articles shortlisted, as many as 393(81%) articles were on plants and the strategy remained the evaluation of one or other extract or compound from a plant for efficacy, safety or development of a method. Over half of the studies (See Table 4 ) examined only efficacy of one or more plants (upto 662 extracts from 222 plants in one paper) (Panda et al., 2016 ). An additional 40 described methods for identification of active molecules/marker compounds (n=17) or safety studies (n=22) along with efficacy.
Unfortunately, there were as many plants as the papers! This was similar to the observation in a previous publication (Thatte U, 2009 ). There was no commonality of purpose, no thread in the diseases covered, no direction. With 311 original articles and 82 reviews, there is still no evidence to change practice.
Although this review is almost a decade after the editorial mentioned earlier, (Thatte U, 2009 ) there has been no appreciable change in research priorities or parts of plants researched upon. As many as 82/ 483 (17%) use droots/rhizomes, the stem-bark or even the whole plant, which makes sustainability a challenge.
Extracts or Pure Compounds
Several papers did not adequately describe the material they used in the research (even in the full texts obtained). Of those that had the details (a total of 263/483), 164/263 (62%) used extracts while 65/ 263 (25%) used pure compounds and 34/263 (13%) used both. The extracts used ranged from aqueous (n=60) to hydroalcoholic -both ethanol and methanol (n=18), ethanol (n=57), methanol (n=58), chloroform Over 200 pure compounds derived from plants have been tested in the published papers with curcumin being tested four times over (for as many conditions including immunomodulation (Kumar et al., 2015) , in vitro effect on muscle contractility (Manvizhi et al., 2015) , amelioration of oxidative stress (Agrawal et al., 2015) and effects in ulcerative colitis (Baliga et al., 2012) and swertiamerine being studied in three reports from the same group for its anti-inflammatory effects (Saravanan et al., 2014a,; Saravanan et al., 2014b; Saravanan et al., 2014c) . Mangiferrin (both papers describing chromatographic methods to quantify it; Naveen et al., 2017 , Kshirsagar et al., 2016 , safranal [one a review (Dawalbhakta et al., 2017) describing patents on both therapeutic and cosmetic uses of active compounds of Crocus sativus and the other an original paper describing efficacy in rat ischemia reperfusion model (Bharti et al., 2012) ], chrysin [insulin signaling (Satyanarayana et al., 2015) , apoptosis (Laishram et al., 2015) ] and cantharidine (cytotoxicity) have been studied in two studies each. Andrographolide (AG) has been studied for hepatoprotection in vitro (Mittal et al., 2016) and, from a drug development point of view an important paper (albeit an experimental study in rats) describes the pharmacokinetics of andrographolide (Bera et al., 2014) . This study developed and standardized a sensitive LC-MS/MS method for AG and found that the highest concentration of AG was in the kidney (156.12 ng/g) followed by liver, spleen and brain, with an elimination half-life and total exposure (AUC) of 2.45 hours and 278.44 ngh/ml, respectively. Such data is valuable while considering "druggability" of either the pure compound or even the extracts of the plant Andrographis panniculata.
All the other papers separately describe as many compounds.
Diseases Studied
What about the diseases that were targeted in the research on TM in India reported in the past five years? The most common condition studied was cancer (n=37), followed closely by diabetes mellitus (n=30). Interestingly, 16 papers looked at various infectious diseases including dengue (n=2) and malaria (n=5). The papers on dengue had one reporting the anti-viral effects of the alcoholic extract of Cissampelos pareira using a systematic bioassayguided screening approach (Sood et al., 2015) and the other describing the effects of Bruguiera cylindrica (a mangrove)-synthesized nanoparticles against dengue virus DEN-2 (in vitro) and its mosquito vector, Aedes aegypti (Murugan et al., 2015) .
Interestingly, a field study described the effects of TPMP74 (a coded polyherbal traditional remedy, with each plant's aqueous extract standardized using accepted methods) in malaria prophylaxis. The study was conducted in healthy participants (n=267) recruited from two villages [Tunpar (experimental village) and Kellar (control village)] of Koraput district of Odisha state, India, during the period of high malaria transmission (June to December 2009). The test group was administered 45mL of the decoction twice a week (on an empty stomach) for 14 weeks. During the study period, 14/113 of the experimental group (incidence rate = 12.3%) and 41/154 of the control group (incidence rate = 26.6%; p=0.005) developed malaria (Nagendrappa et al., 2017 ). Yet another clinical study in malaria (an open label non-comparative design) explored the effects of the paste of fresh leaves of Nyctanthes arbor-tristis in malaria (Godse et al., 2016) . This study was exploratory in nature, where 10/20 patients showed both fever and parasite clearance. The remaining ten patients had persistent but decreasing parasitemia. Only 4 patients needed chloroquine as a rescue medication. There was an associated increase in platelet count and normalization of plasma lactic acid, improvement in organ function and good clinical tolerability. The inflammatory cytokines (particularly in TNFá) showed a reduction.
The other three studies were experimental and investigated Albizia lebbeck (Kalia et al., 2015) , Berberis aristata (Chandel et al., 2015) and 8 plants of which the aqueous extract of Phyllanthus amarus and chloroform extract of Murraya koenigii were found effective (Keluskar et al., 2012) in mice models or in vitro. None of these leads appear to have been followed.
Other disease conditions explored included wound healing (n=7), arthritis and inflammation (n=16), asthma (n=4) or diarrhea (n=3) and many varied and disparate conditions including alcohol dependence, anxiety, ageing to male sexual dysfunction and liver disease.
Papers on In vitro and Animal Experimentation
Of all the 483 papers, as many as 155 were experimental studies and used rats (n=98), mice (n=50), guinea pigs (n=4) or hamsters (n=1), a couple using more than one species in the work. Almost as many as the experimental studies, 152/483 described in vitro work -largely tests for antioxidant activity (n=41) using mostly chemical assays or cytotoxicity studies (n=31) using a range of cell lines (such as HepG2 cells, MCF-7 (Human mammary gland adenocarcinoma), Caco-2 cell monolayers, H9c2 cells, A172-Glioblastoma, DLD-1-Colorectal adenocarcinoma, PLC/PRF/5-Liver hepatoma, A549-Lung carcinoma, SK-OV-3-Ovarian carcinoma, BxPC-3-Pancreatic adenocarcinoma, DU145-Prostate carcinoma, and Caki-1-Renal carcinoma). There were 7 papers describing in silico work -involving the study of Clitoria ternatea in neurodegenerative diseases and depression (Margret et al., 2015) , the potential ligand target interactions of Chebulagic acid from Terminalia chebula with PPARã (Shyni et al., 2014) , the immunoprotective effects of curcumin in thymocytes apoptosis (Kumar et al., 2015) , anti-inflammatory effects of swertiamarine from Enichostemma littorale (Saravanan et al., 2014a; Saravanan et al., 2014b) and the fluorescence quenching effects of 5hydroxy3',4',7trimethoxyflavone from Lippia nodiflora (Sudha et al., 2015) as well as male contraceptive action of piperine (Chinta et al., 2015) .
Papers on Clinical Investigations
Unfortunately, this search revealed only a total of 9 papers describing clinical investigations, two of which have been alluded to earlier (malaria studies) (Nagendrappa et al., 2017 , Godse et al., 2016 . A controlled clinical trial to compare the efficacy of two Ayurvedic procedure-based treatments: Navarakizhi, (a massage of cooked navara rice in a medicated hot bolus), and pinda sweda, (a massage made of a different type of rice) given for 7 days in 18 patients of hemiplegia (Guruprasad et al., 2014) . Patients who received navarakizhi recovered better than those who received pinda sweda. In another study, conducted in 116 healthy, non-smoking, non-alcoholic males between the ages of 45 and 60 years received Amalaki Rasayana or placebo (for 45 days) starting a day after several pre-procedures (Koshta Shuddhi) including snehana (oleation), abhyanga and bashpa swedha (fomentation or sudation), virechana (purgation) and samsarjana (normalization of diet). Younger individuals (n=51) between 22 and 30 years age group were also included to compare the differences between young and aged. Among other findings, interestingly these authors found a significant increase (p < 0.05) in the telomerase activity on the 90th day in the age group of 45-52 years administered amalaki rasayana (5.49 ± 0.55) when compared to the respective placebo group (3.92 ± 0.38) (Guruprasad et al., 2017) .
The effects of shirodhara (a procedure described in Ayurveda) were studied in 16 healthy volunteers by measuring mood and stress levels as well EEG patterns. The authors found a significant reduction in stress levels and an improvement in mood, along with a reduction in respiratory rate and heart rate as well as diastolic BP and increase in ?rhythm in EEG (Dhuri et al., 2013) . Interestingly, a couple of landmark papers have investigated modern correlates of the prakriti concept so greatly emphasised in Ayurveda. One study conducted in a total of 3416 healthy male, non-smoking, non-alcoholic participants between the age group of 20 and 30 found significant correlations of the dominant prakriti to place of birth and BMI (p < 0.01) (Rotti et al., 2014) . A genomewide single nucleotide polymorphism analysis of 262 well-classified male individuals found 52 SNPs (p < 1 x 10 -5 ) were significantly different between Prakritis, without any confounding effect of stratification, after 10 6 permutations) (Govindaraj et al., 2015) .
A review paper discussed the role of Traditional Medicines and kidney disease in low-and middleincome countries. Both the harms and benefits of the Indian traditional medicines, with a special focus on Ayurveda, were described in this paper (Stanifer et al., 2017) , while another review covered the management of adverse drug reactions using Ayurvedic treatment (Jadav et al., 2013) .
Papers on Safety
There were n = 3 papers describing adverse reactions to traditional medicine practices including acute renal failure, following ingestion of an Ayurvedic medicine containing mercury (Sathe et al., 2013) harmful traditional healing practices in the treatment of lymphatic filariasis (Narahari et al., 2016) and a very disturbing paper on the risk of congenital malformations following the use of TM for sex selection during pregnancy (Neogi et al., 2015) .
Papers on Methodology
Among the methods described for measuring biomarkers/active molecules were HPLC (n=20), GCMS (n=9), HPTLC (n=8), LCMS (n=4) and TLC (n=5). Methods to identify plants including bar-coding (see below) and genome wide analysis (GWAS; Lin et al., 2017) have been reported. Bar coding has been described as a method to detect adulteration in plant materials (Urumarudappa et al., 2016) and Vassou et al (2016) have DNA barcoded 347 medicinal plants using the rbcL marker.
The recent phytopharmaceutical notification GSR 918(E) (CDSCO 2015) a "Phytopharmaceutical drug includes purified and standardised fraction with defined minimum four bio-active or phyto-chemical compounds (qualitatively and quantitatively assessed) of an extract of a medicinal plant or its part, for internal or external use of human beings or animals for diagnosis, treatment, mitigation or prevention of any disease or disorder but does not include administration by parenteral route." None of the publications could lead to a "drug" as they are deficient in many of the data requirements prescribed in this notification.
Surveys
As seen in the Table 4 , as many as 66/483 (13%) of the papers identified were field surveys recording traditional medicine practices either documenting all the plants (and sometimes insects) used by tribes or recording the treatments used for certain diseases. Table 5 lists all the areas (and if named, the tribes) that have been studied. Over 5000 (5238) plants have been identified and recorded in addition to 90 toxic plants and 51 insect species in these field surveys.
Description of Therapeutic Areas Covered in Surveys
The management of Diabetes mellitus, lithiasis, sexual and gynaecological disorders, tuberculosis, cancer, dentistry, wound healing, epilepsy, jaundice, and GI disorders using TM in various tribes has been described in 11 surveys. Interestingly, one survey has recorded 41 plants used in treatment of camels in the Shiwalik areas of Kathua .
Papers Related to General Issues in TM
Apart from the publications related to pharmacological actions of plants, there have been (in the last five years), a few papers that are related to traditional medicine use in the country that bear special mention. For example, a comprehensive survey on usage of AYUSH (acronym for Ayurveda, naturopathy and Yoga, Unani, Siddha, and Homeopathy) in India at the household level throws up surprising figures -less than 30% of Indian households use the traditional medical systems. There is also a regional pattern in the usage of a particular type of traditional medicine, reflecting the regional aspects of the development of such medical systems. The strong faith in AYUSH is the main reason for its usage; lack of a perceived need for AYUSH and lack of awareness about AYUSH are the main reasons for not using it . Interestingly, a WHO-SAGE survey (Oyebode et al., 2016) also revealed that although TM use was highest in India, only 11.7% of people reported that their most frequent source of care during the previous 3 years was TM and only 19.0% reported TM use in the previous 12 months suggesting that TM is not after all so widely used.
An excellent review (Lakshmi et al., 2015) , a product of an international collaborative effort has reported the determinants, patterns and incorporation of different traditional systems of medicine in the public health systems in low and middle income countries with a particular focus on India. The main findings of this review are not surprising -that allopathy has been established as the mainstream medical system, along with the legitimation (or in some cases, de-legitimation) of different traditional, complementary and alternative systems of medicine, and finally the establishment of a pluralistic health system. It is expectedly the need to address the disease Traditional Medicine: A Review of Work in India (2012 273 paper by Pillai and Sharma (2014) describes 7 models of integration, the many ethical and legal aspects that need to be addressed, while integrating various health care systems are well described by Math et al. (2015) .
Additional Publications
A few papers that did not show up on the primary search but have been identified through discussions with experts in the field are discussed below. burden borne by the public health system that leads to the inclusion of traditional medicine health providers in the public health workforce. The review also refers to the potential ethical and operational challenges of the administration of a "plural" workforce, even though this type of a pluralistic medical society would offer patients more options.
Mainstreaming traditional medicine has been in the forefront of many discussion fora, and while the 274
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Clinical Studies
Work on rasayanas of Ayurveda has fascinated scientists since long. Similar to another paper on the same medicine (Guruprasad et al., 2017) , freshly prepared Amalki rasayana given for 45 days to elderly, otherwise healthy, elderly participants maintained/enhanced DNA strand break repair without any adverse effects (Vishwanatha et al., 2016) .
Shilajit is yet another widely used drug in traditional medicine and is considered to be a rasayana. In a randomised, double-blind, placebo-controlled clinical study conducted in healthy individuals between 45 and 55 years age, shilajit at a dose of 250 mg twice a day, increased total and free testosterone and dehydroepiandrosterone (Pandit et al., 2016) .
Terminalia arjuna has been studied extensively in cardiac conditions and a publication by Maulik et al. (2016) reported that a water extract of stem bark of Arjuna (Arjuna extract; 750 mg) given over 12 weeks did not improve left ventricular ejection fraction (LVEF) in patients with congestive heart failure in a double-blind, parallel, randomized, placebo-controlled add-on clinical trial although the dame plant has been shown to produce anti-inflammatory actions in patients with coronary artery disease (Kapoor et al., 2015) .
Diabetes mellitus is the major target of many traditional medicines, although well-conducted clinical trials are few and far between. In a randomized, controlled study, 93 newly diagnosed patients with Type-2 diabetes mellitus were randomly allocated to receiving a "polyherbal capsule" (500 mg/day, uptitrated weekly to a maximum of 3 g/day) or Metformin 500 mg/day, up-titrated weekly to a maximum of 2 g/ day) over 24 weeks. The herbal formulation produced hypoglycemic effects similar to metformin (Awasthi et al., 2015) .
Similarly, like diabetes, arthritis is another target disease for traditional medicine therapies and studies have evaluated plants like Ashwagandha and agents like Sidh Makardhwa) (Kumar et al., 2015) or Ayurvedic formulations (extracts of Tinospora cordifolia, Zingiber officinale, Emblica officinalis, Boswellia serrata) (Chopra et al., 2013) with some success. The analgesic activity of Boswellia serrata was further confirmed in a human model of pain (Prabhavathi et al., 2014) . Other studies have evaluated various therapies like Ayushman-15 (an Ayurvedic polyherbal preparation) in major depression (Kishore et al., 2014) , Ayurvedic therapies like Mauktikyukta Kamdudha and Mauktikyukta Praval Panchamruta in patients receiving cancer chemotherapy to reduce adverse effects (Deshmukh et al., 2014) , Withania somnifera in infertility (Gupta et al., 2013) and an Ayurvedic regime in cirrhosis (Patel et al., 2015) . Unani medicines have been tried with some success in Pityriasis versicolor (Lone et al., 2012) .
Ayurvedic Biology
Under the leadership of Dr MS Valiathan, the program of Ayurvedic Biology was taken up with support from Office of the Principal Scientific Adviser to the Government of India, and the Department of Science and Technology (Valiathan et al., 2016) . The main objective of these projects was to apply scientific methods in the study of Ayurvedic concepts, procedures and mechanistic basis of therapeutic effects. The work on the genomics correlates of the prakriti concept has already been alluded to (Govindaraj et al., 2015) .
This work was further supported by the results of an epigenetic study based on DNA methylation for differentiating the three prakrits (Rotti et al., 2015) .
The Ayurveda Biology project also delved into the effects of Amalki rasayana [mentioned earlier (Guruprasad et al., 2017 , Vishwanatha et al., 2016 ]. Rasayana fed rats had significantly less DNA damage in neurons and astrocytes in the brain as compared to control rats (Swain et al., 2012) . Similarly, Dwivedi et al. (2012) showed beneficial effects in a series of studies on the Drosophila melanogaster, including suppression of neuro-degeneration in fly models of Huntington's and Alzheimer's diseases without side effects (Dwivedi et al., 2013) and suppression of apoptosis in these models (Dwivedi et al., 2015) .
In addition, the concept of Panchakarma was also explored and basti (enema) was shown in a clinical trial to produce significant weight reduction as also significant decrease in serum interferon (IFN)-Y and interleukin (IL6), and gradual reduction in IL8 level suggesting that basti reduced pro-inflammatory cytokines which are raised in obesity (Thatte et al., 2015) . In another study, Rasasindura (made of mercury and sulphur) was shown to have the same structure as non-toxic HgS and toxic chemical forms of mercury were completely absent in the study sample and nano-crystal units of Rasasindura were free of organic molecules (Ramanan et al., 2015) .
The Way Forward
A few review articles have addressed the issue of research in TM. One review identifies some of the flaws in the conduct of clinical research in TM including small sample sizes, variable or inconsistent results, inadequate research designs, insufficient statistical power, poor controls, and inadequate descriptions of the investigational product. This review further describes the need for evolving research methods that can take into consideration the "holistic" approach in therapy with TM (Telles et al., 2014) . Some very useful directions for the future have been stated that should be considered by policy makers and academicians alike; including policy making, training of researchers in TM with a combination of conventional research methods and those relevant exclusively to TM, better research budgets and guidelines for writing and reviewing research grant proposals, and research in research methods! Other papers echo similar thoughts and describe the challenges and solutions for clinical research on Ayurveda (Chauhan et al., 2015) ; clinical trials on herbal medicines (Parveen et al., 2015) ; or drug development from herbs (Mandal et al., 2012) .
If research were to become the focus of the future, there is a need to address the training needs of the researchers! This is well illustrated in a questionnaire-based paper that reports that 75.4% of the respondents of the survey did not receive any structured training on research methodology which included those that had received government funding! The respondents working in research organizations, government organizations, and academic institutions had lower knowledge compared to those who were in private organizations/practice (Narahari et al., 2014) .
Conclusions
It is clear from this data that the large part of work that is undertaken carrying the heading of TM is related to plant pharmacology with no efforts to develop a drug from them. There is indeed very little work (especially original) related to "Traditional Medicine" as defined by the WHO. Over 400 publications indicate an expenditure of considerable sums of money on the research, as well as an expenditure of man-hours and energy -but all to what avail? And it is worrisome that there must be at least 10 times similar research that has not been published which would have been funded! There is very little focus on applied research -no effort to develop a drug that could prove useful for the various unmet medical needs that India faces currently (Thatte, 2009) . 
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